I think it's already here. I've read occasional posts, (I don't recall where, offhand), by people who had adverse drug reactions, (or sudden lack of efficacy from their medication), and when they checked, they discovered that their pharmacy had changed brands, or changed to a generic, in response to orders from the customer's insurance company, without even bothering to inform the customer. I understand that they have the right to do that, unless their doctor specifically marks the prescription to disallow any changes by the pharmacy. I suspect that might be an everyday problem with government-run health care systems.Luce wrote:but I just fear that one day this may lead to our being almost forced to take a treatment we'd prefer not to for fear of some sort of punitive action from the insurance company, particularly if it's an all powerful government system.
While I was talking with my neuro doc, (after the session), he asked me if I was ready for a goverment-run system. I told him that I was hoping that it would never come about, so then he told me about the government health care system in India, (where he is from). He told me all sorts of things about it, that didn't sound very appealing, but the last line was, "You wouldn't take your dog to a government hospital in India".
Tex
P. S. Our doctors, the pharmacies, and Big Pharma, have to share information about us - otherwise, they wouldn't be able to properly divide up all the kickbacks. Yes, I'm sure that Asacol pays much better than Entocort EC, because Prometheus Labs, (the current owner of Entocort EC), is a very stingy company. Most companies offer patient assistance, for hardship cases - those patients are out of luck with Prometheus. Or, it could be that Prometheus is not really stingy, but AstraZeneca is robbing them blind for the patent rights. AstraZeneca used to offer patient assistance, before they sold the product rights to Prometheus. Anyway, I suspect that's the main reason why most GI docs don't want to keep a patient on Entocort EC any longer than they have to. The cost to the patient is roughly the same, with either product, I believe. Asacol, however, is a much older product, so it had to cost much less to develop and get to market, than Entocort EC. That's why I'm pretty sure that it pays much better than Entocort. I would assume that it's illegal, for doctors to get direct payments, for a prescription, but there are other ways to provide compensation, of course.